Figures 7 and 8 show the effect of PDE3A modulation on the various markers of neuroinflammation and BBB function in the inflammation (LPS)-induced and CAA-associated CMH mouse models. Here, PDE3A is linked to hypertrophic cardiomyopathy 1.